Literature DB >> 8537112

Motif of HLA-B*3503 peptide ligands.

A Steinle1, K Falk, O Rötzschke, V Gnau, S Stevanović, G Jung, D J Schendel, H G Rammensee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8537112     DOI： 10.1007/bf00186615

Source DB:  PubMed          Journal:  Immunogenetics        ISSN： 0093-7711            Impact factor:   2.846


× No keyword cloud information.
  18 in total

1.  Emerging principles for the recognition of peptide antigens by MHC class I molecules.

Authors:  M Matsumura; D H Fremont; P A Peterson; I A Wilson
Journal:  Science       Date:  1992-08-14       Impact factor: 47.728

2.  A human beta-actin expression vector system directs high-level accumulation of antisense transcripts.

Authors:  P Gunning; J Leavitt; G Muscat; S Y Ng; L Kedes
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

3.  Molecular mapping of a new public HLA class I epitope shared by all HLA-B and HLA-C antigens and defined by a monoclonal antibody.

Authors:  J A Trapani; S Mizuno; S H Kang; S Y Yang; B Dupont
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

4.  Fine tuning of peptide binding to HLA-B*3501 molecules by nonanchor residues.

Authors:  C Schönbach; M Ibe; H Shiga; Y Takamiya; K Miwa; K Nokihara; M Takiguchi
Journal:  J Immunol       Date:  1995-06-01       Impact factor: 5.422

5.  Peptide motifs of HLA-B51, -B52 and -B78 molecules, and implications for Behćet's disease.

Authors:  K Falk; O Rötzschke; M Takiguchi; V Gnau; S Stevanović; G Jung; H G Rammensee
Journal:  Int Immunol       Date:  1995-02       Impact factor: 4.823

6.  Peptide motifs of HLA-B35 and -B37 molecules.

Authors:  K Falk; O Rötzschke; B Grahovac; D Schendel; S Stevanović; G Jung; H G Rammensee
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

7.  Microheterogeneity in HLA-B35 alleles influences peptide-dependent allorecognition by cytotoxic T cells but not binding of a peptide-restricted monoclonal antibody.

Authors:  A Steinle; C Reinhardt; E Nössner; B Uchanska-Ziegler; A Ziegler; D J Schendel
Journal:  Hum Immunol       Date:  1993-12       Impact factor: 2.850

8.  Grouping HLA-B locus serologic specificities according to shared structural motifs suggests that different peptide-anchoring pockets may have contrasting influences on the course of HIV-1 infection.

Authors:  S Itescu; S Rose; E Dwyer; R Winchester
Journal:  Hum Immunol       Date:  1995-01       Impact factor: 2.850

9.  HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women.

Authors:  S Rowland-Jones; J Sutton; K Ariyoshi; T Dong; F Gotch; S McAdam; D Whitby; S Sabally; A Gallimore; T Corrah
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

10.  Polymorphism of human minor histocompatibility antigens: T cell recognition of human minor histocompatibility peptides presented by HLA-B35 subtype molecules.

Authors:  Y Beck; L Satz; Y Takamiya; S Nakayama; L Ling; Y Ishikawa; T Nagao; H Uchida; K Tokunaga; C Müller
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307
View more
  9 in total

1.  Increased diversity of the HLA-B40 ligandome by the presentation of peptides phosphorylated at their main anchor residue.

Authors:  Miguel Marcilla; Adán Alpízar; Manuel Lombardía; Antonio Ramos-Fernandez; Manuel Ramos; Juan Pablo Albar
Journal:  Mol Cell Proteomics       Date:  2013-12-23       Impact factor: 5.911

2.  A Molecular Basis for the Presentation of Phosphorylated Peptides by HLA-B Antigens.

Authors:  Adán Alpízar; Fabio Marino; Antonio Ramos-Fernández; Manuel Lombardía; Anita Jeko; Florencio Pazos; Alberto Paradela; César Santiago; Albert J R Heck; Miguel Marcilla
Journal:  Mol Cell Proteomics       Date:  2016-12-05       Impact factor: 5.911

3.  Distinct assembly profiles of HLA-B molecules.

Authors:  Syed Monem Rizvi; Nasir Salam; Jie Geng; Ying Qi; Jay H Bream; Priya Duggal; Shehnaz K Hussain; Jeremy Martinson; Steven M Wolinsky; Mary Carrington; Malini Raghavan
Journal:  J Immunol       Date:  2014-04-30       Impact factor: 5.422

Review 4.  HLA/KIR restraint of HIV: surviving the fittest.

Authors:  Arman A Bashirova; Rasmi Thomas; Mary Carrington
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

5.  Assembly and intracellular trafficking of HLA-B*3501 and HLA-B*3503.

Authors:  Vilasack Thammavongsa; Malinda Schaefer; Tracey Filzen; Kathleen L Collins; Mary Carrington; Naveen Bangia; Malini Raghavan
Journal:  Immunogenetics       Date:  2009-12       Impact factor: 2.846

Review 6.  Immunogenetics of HIV disease.

Authors:  Maureen P Martin; Mary Carrington
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

Review 7.  Impact of MHC class I diversity on immune control of immunodeficiency virus replication.

Authors:  Philip J R Goulder; David I Watkins
Journal:  Nat Rev Immunol       Date:  2008-08       Impact factor: 53.106

8.  Understanding the obstacle of incompatibility at residue 156 within HLA-B*35 subtypes.

Authors:  Trishna Manandhar; Heike Kunze-Schumacher; Trevor Huyton; Alexander A Celik; Rainer Blasczyk; Christina Bade-Doeding
Journal:  Immunogenetics       Date:  2016-01-12       Impact factor: 2.846

9.  The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove.

Authors:  Minzhong Tang; James A Lautenberger; Xiaojiang Gao; Efe Sezgin; Sher L Hendrickson; Jennifer L Troyer; Victor A David; Li Guan; Carl E McIntosh; Xiuchan Guo; Yuming Zheng; Jian Liao; Hong Deng; Michael Malasky; Bailey Kessing; Cheryl A Winkler; Mary Carrington; Guy Dé The; Yi Zeng; Stephen J O'Brien
Journal:  PLoS Genet       Date:  2012-11-29       Impact factor: 5.917
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.